Richard Pazdur, MD, director of the FDA’s Oncology Center of Excellence, will present Expediting Oncology Drug Development in an Era of Breakthrough Therapies from 12-1P on March 31 in Fukushima Auditorium.
The Oncology Center of Excellence leverages the combined skills of the FDA’s regulatory scientists and reviewers with expertise in drugs, biologics and devices to expedite the development of novel cancer products as part of the Vice President’s National Cancer Moonshot Initiative. The special seminar is being presented by the WVU Cancer Institute.
Patrick Ma, M.D., co-leader of the WVU Cancer Institute Sara Crile Allen & James Frederick Allen Comprehensive Lung Cancer Program and director of the Clinical Lung Cancer Program, and Xiaoliang Wu, M.D., Ph.D., postdoctoral research fellow in Dr. Ma’s lab, were featured presenters at the 2018 American Society of Clinical Oncology (ASCO) Annual Scientific Meeting this June.
The National Institutes of Health (NIH) Common Fund announces fiscal year 2019 funding opportunities for the NIH Director’s Pioneer Award, New Innovator Award, Transformative Research Award, and Early Independence Award in the High-Risk, High-Reward Research program.
West Virginia University researchers may have uncovered the cause of muscle fatigue in breast cancer patients.